MIAMI--(BUSINESS WIRE)--Vector Group Ltd. (NYSE:VGR) (“Vector” or the “Company”) today announced that it intends to offer and sell, subject to market and other conditions, $150.0 million aggregate ...
Furthermore, our recent demonstrations that overexpression of cathepsin L in human tumor cells is under the control of separate and complex regulatory mechanisms 20, 21 support that procathepsin L ...
MIAMI--(BUSINESS WIRE)-- Vector Group Ltd. (NYS: VGR) ("Vector" or the "Company") today announced the pricing of its previously announced public offering of $200.0 million aggregate principal amount ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results